-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, FypL8KB0lTsweu6jxJnyIfrU833KyOhYAzeeEozJinoRnvmdcWig+/JDnAzmguaI E8NkfLh4XXuWAk0kL0GTsQ== 0001181431-06-011967.txt : 20060215 0001181431-06-011967.hdr.sgml : 20060215 20060215193835 ACCESSION NUMBER: 0001181431-06-011967 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20060213 FILED AS OF DATE: 20060215 DATE AS OF CHANGE: 20060215 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: HOLLIS EDEN PHARMACEUTICALS INC /DE/ CENTRAL INDEX KEY: 0000899394 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 133697002 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 4435 EASTGATE MALL STREET 2: SUITE 400 CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 858-587-9333 MAIL ADDRESS: STREET 1: 4435 EASTGATE MALL STREET 2: SUITE 400 CITY: SAN DIEGO STATE: CA ZIP: 92121 FORMER COMPANY: FORMER CONFORMED NAME: INITIAL ACQUISITION CORP DATE OF NAME CHANGE: 19930329 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: HOLLIS RICHARD B CENTRAL INDEX KEY: 0001056208 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-24672 FILM NUMBER: 06623389 BUSINESS ADDRESS: BUSINESS PHONE: 6195879333 MAIL ADDRESS: STREET 1: 9333 GENESEE AVENUE STREET 2: SUITE 110 CITY: SAN DIEGO STATE: CA ZIP: 92121 4 1 rrd108279.xml FORM 4 X0202 4 2006-02-13 0 0000899394 HOLLIS EDEN PHARMACEUTICALS INC /DE/ HEPH 0001056208 HOLLIS RICHARD B 4435 EASTGATE MALL, SUITE 400 SAN DIEGO CA 92121 1 1 1 0 Chairman and CEO Common Stock 2006-02-13 4 A 0 24000 0 A 2290499 D Stock Option (Right to Buy) 6.20 2006-02-13 4 A 0 72000 0 A 2016-02-12 Common Stock 72000 72000 D Restricted stock award granted under the Issuer's 2005 Equity Incentive Plan, as amended. Includes 2,158 shares of Issuer's common stock acquired by the Reporting Person under the Issuer's 401(k) Plan. The information in this report is based on a plan statement dated as of December 31, 2005. 25% of the shares subject to the Stock Option shall vest and become exercisable on the first anniversary of the date of grant. The balance of the shares shall vest and become exercisable in 36 equal monthly installments thereafter. /s/ Eric J. Loumeau, Attorney-In-Fact 2006-02-15 -----END PRIVACY-ENHANCED MESSAGE-----